Antipsychotics Market to 2017 – Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules
andnbsp;
GBI Research, the leading business intelligence provider, has released its latest research andldquo;Antipsychotics Market to 2017 – Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Moleculesandrdquo;
GBI Research Reports
Related posts:
- Pain Management Therapeutics Market to 2017 – Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
- Pricing and Reimbursement in the US – Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
- Continuous Glucose Monitoring (CGM) Systems – Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- Stem Cell Research Market to 2017 – Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D
- Multiparameter Patient Monitoring – Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Author: admin
This author has published 2797 articles so far. More info about the author is coming soon.